Related Experiment Videos
Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis
Marcus Baumann1, Oliver Witzke, Ali Canbay
1Department of Nephrology, University Clinic Essen, Germany.
Hepato-Gastroenterology
|September 15, 2004
Summary
Serum complement levels of C3 and C4 are linked to liver cirrhosis severity. Lower C3 concentrations indicate a higher risk of hepatorenal syndrome in advanced cirrhosis patients.
Area of Science:
- Immunology
- Hepatology
- Clinical Biochemistry
Background:
- Liver cirrhosis is a significant health concern.
- Prognostic markers are crucial for managing liver cirrhosis.
- Complement system proteins C3 and C4 play roles in immune responses.
Purpose of the Study:
- To determine the prognostic value of serum complement C3 and C4 concentrations in liver cirrhosis patients.
- To investigate the correlation between complement levels and liver disease severity.
Main Methods:
- Serum C3 and C4 concentrations were measured in 69 liver cirrhosis patients.
- Complement levels were correlated with the Child-Pugh score, a measure of cirrhosis severity.
- Subgroup analysis included patients who developed hepatorenal syndrome (HRS).
Main Results:
- Serum C3 and C4 concentrations showed a significant negative correlation with the Child-Pugh score.
- C3 levels decreased progressively from Child-Pugh A to C cirrhosis.
- Patients developing hepatorenal syndrome had significantly lower C3 concentrations compared to those without HRS.
Conclusions:
- Serum C3 and C4 levels are valuable prognostic indicators in liver cirrhosis.
- Decreased C3 concentrations are associated with increased cirrhosis severity and the development of hepatorenal syndrome.
- Complement component levels may aid in risk stratification for liver cirrhosis patients.